Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:PPD PPD (PPD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About PPD Stock (NASDAQ:PPD) 30 days 90 days 365 days Advanced Chart Ad Porter & CompanyThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Get PPD alerts:Sign Up Key Stats Today's Range$47.28▼$47.2850-Day Range$47.10▼$47.4152-Week Range$31.54▼$47.41VolumeN/AAverage Volume1.91 million shsMarket Capitalization$16.61 billionP/E Ratio47.28Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.Read More… The real reason Elon is fully endorsing Trump (Ad)Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. Watch this new documentary and you’ll discover what Elon knows, Receive PPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PPD and its competitors with MarketBeat's FREE daily newsletter. Email Address PPD Stock News HeadlinesGirl found safe, Amber Alert cancelledOctober 17 at 8:32 PM | msn.comPineville police searching for murder suspectOctober 17 at 8:32 PM | msn.comDeFi Coin on Verge of Breakout!Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… October 18, 2024 | Crypto 101 Media (Ad)PPD: Teen punched man who tried to get him to do drugsOctober 17 at 8:32 PM | msn.comPPD: Suspect arrested after reporting false kidnappingOctober 17 at 3:30 PM | msn.comA New Mom Hates Her Baby's Name So Much That She ‘Dreads Saying It' & Reddit Is Begging Her To Take ActionOctober 17 at 9:21 AM | msn.comPensacola police arrest 20-year-old accused of burglarizing 7 churches over 3-week spanOctober 16 at 8:40 AM | msn.comWanted Floyd County man reportedly leads police on 120+ mph chase, reports his truck stolenOctober 16 at 8:40 AM | msn.comSee More Headlines PPD Stock Analysis - Frequently Asked Questions How were PPD's earnings last quarter? PPD, Inc. (NASDAQ:PPD) issued its quarterly earnings data on Wednesday, October, 27th. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.05. The business's revenue was up 26.5% on a year-over-year basis. When did PPD IPO? PPD (PPD) raised $1.5 billion in an IPO on Thursday, February 6th 2020. The company issued 60,000,000 shares at a price of $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair served as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers. What other stocks do shareholders of PPD own? Based on aggregate information from My MarketBeat watchlists, some other companies that PPD investors own include Meta Platforms (META), Pfizer (PFE), NVIDIA (NVDA), Salesforce (CRM), Taiwan Semiconductor Manufacturing (TSM), Alibaba Group (BABA) and Advanced Micro Devices (AMD). Company Calendar Last Earnings10/27/2021Today10/17/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:PPD CUSIPN/A CIK1793294 Webwww.ppdi.com Phone910-251-0081FaxN/AEmployees26,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.00 Trailing P/E Ratio47.28 Forward P/E Ratio32.16 P/E Growth2.11Net Income$153.69 million Net Margins6.11% Pretax Margin7.31% Return on Equity-89.48% Return on Assets7.94% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$4.68 billion Price / Sales3.55 Cash Flow$1.99 per share Price / Cash Flow23.71 Book Value($1.21) per share Price / Book-39.07Miscellaneous Outstanding Shares351,395,000Free Float344,718,000Market Cap$16.61 billion OptionableNot Optionable Beta1.96 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (NASDAQ:PPD) was last updated on 10/18/2024 by MarketBeat.com Staff From Our PartnersAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredDeFi Coin on Verge of Breakout!Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored3 Billionaires Dump Nvidia Shares. What Do They Know That You Don’t?Dan Ferris's research has been trusted by names at America's top investment banks, like JP Morgan and Barclays...Stansberry Research | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMassive trading opportunity begins by October 21 October 21 could spark a mania among “next-generation” AI stocks. That’s the newest prediction from a Wall Str...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PPD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PPD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.